Hryz Bio Tech

Hryz Bio Tech

Private
ShanghaiHealthcare & Life Scienceshttps://wanwang.aliyun.com/hosting/ipvisit_stop

Last Round

Series C

Extension

Jan 9, 2024

Total Funding Raised

$42.5M

Company Overview

Hryz Bio Tech is a biotechnology company that develops immune cell therapy technologies for solid tumors, with product pipelines including MASCT, TCR-T, and TCR Dual Antibody.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

TCR-T therapycell therapysolid tumor therapycell and gene therapyCGTcancer immunotherapyengineered T-cellsTCR technologyautologous cell therapygene therapyGMP manufacturingMASCTclinical-stage biotechTCR screening platformTCR dual antibody

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hryz Bio Tech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hryz Bio Tech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionJan 9, 2024
Series C ExtensionAug 31, 2023
Series CMay 16, 2023
Series B ExtensionDec 6, 2022
Series BDec 28, 2020
Series A Extension
Sep 2, 2020

Hryz Bio Tech Investors

Notable investors and investment history

InvestorRounds
Shenzhen Hengtai Huasheng Asset ManagementSeries A Extension
CCIC CapitalSeries B Extension, Series A Extension
Sincere CapitalSeries B
Zicheng InvestmentSeries A Extension
China Science & Merchants Investment Management GroupSeries B Extension
HongShanSeries B Extension

Hryz Bio Tech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hryz Bio Tech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hryz Bio Tech's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Year Founded2015
Last FundingJan 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.